Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Statistical Methods for Analyzing Epidemiological Data

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:

Statistical Software for Data Analysis and Clinical Trials

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Bacteriophages of the Human Virome

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>YoyoMut</i>: Interactive Exploration of SARS-CoV-2 Mutation Fixation and Reversion Through Time.

Life (Basel, Switzerland)·2026

Same author

Lightweight multiscale early warning system for influenza A spillovers.

Science advances·2025

Same author

BioGAN: Enhancing Transcriptomic Data Generation with Biological Knowledge.

Bioengineering (Basel, Switzerland)·2025

Same author

Systematic analysis of SARS-CoV-2 Omicron subvariants' impact on B and T cell epitopes.

PloS one·2024

Same author

Non-Negative Matrix Tri-Factorization for Representation Learning in Multi-Omics Datasets with Applications to Drug Repurposing and Selection.

International journal of molecular sciences·2024

Same author

Searching COVID-19 Clinical Research Using Graph Queries: Algorithm Development and Validation.

Journal of medical Internet research·2024

Same journal

Anti-Inflammatory Activity of a Phycocyanin-Protein Complex in THP-1 Cells: Implications for Dermocosmetic Applications.

Biotech (Basel (Switzerland))·2026

Same journal

Clinical Outcomes of Metronidazole Monotherapy Versus Metronidazole Plus <i>Clostridium butyricum</i> MIYAIRI 588 Combination Therapy in Non-Severe <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study.

Biotech (Basel (Switzerland))·2026

Same journal

The Gut Microbiome Dependency Continuum in Drug Discovery: A Unified Pharmacology Framework Linking Clinical Drugs, Natural Products, and Engineered Microbial Therapeutics.

Biotech (Basel (Switzerland))·2026

Same journal

Bioinformatics Strategy for 16s and 23s rRNA Metabarcoding Data.

Biotech (Basel (Switzerland))·2026

Same journal

Optimizing Light Intensity for the Co-Production of Fucoxanthin and Polyunsaturated Fatty Acids in <i>Isochrysis galbana</i>.

Biotech (Basel (Switzerland))·2026

Same journal

Regioselective Oxidation of D-Galacturonic Acid to Provide Crystallized Mucic Acid Using Engineered <i>Gluconobacter oxydans</i>.

Biotech (Basel (Switzerland))·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis.

Pietro Pinoli¹, Anna Bernasconi¹, Anna Sandionigi²

¹Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, 20133 Milano, Italy.

Biotech (Basel (Switzerland))

|July 13, 2022

Summary

This summary is machine-generated.

VirusLab offers a flexible system for analyzing SARS-CoV-2 sequences and host data. This powerful tool supports research and surveillance by integrating viral data with clinical information for enhanced diagnostics.

Keywords:

COVID-19 SARS-CoV-2 data integration diagnostics host population mutation analysis virus sequencing

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

Related Experiment Videos

Last Updated: Jun 17, 2026

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

Area of Science:

Virology
Bioinformatics
Computational Biology

Background:

The COVID-19 pandemic created significant challenges for viral data analysis and host disease diagnostics.
Existing tools often lack flexibility and integration capabilities for comprehensive SARS-CoV-2 analysis.

Purpose of the Study:

To introduce VirusLab, a novel, flexible system for analyzing SARS-CoV-2 sequences and their associated host metadata.
To provide a customizable, server-side architecture that integrates existing resources for advanced viral data analysis.

Main Methods:

VirusLab leverages ViruSurf (a SARS-CoV-2 sequence database) and VirusViz (a visualization tool).
It employs a customizable, server-side architecture supporting pipelines like ARTIC and Galaxy.
The system preprocesses sequencing data from Oxford Nanopore and Illumina, accesses public datasets, and generates user-friendly reports.

Main Results:

VirusLab provides a unique, integrated solution for SARS-CoV-2 sequence and host data analysis.
The system generates powerful, machine-readable tabular and graphical reports.
It is designed for secure, on-premises installation, enabling integration with sensitive clinical metadata.

Conclusions:

VirusLab is a powerful, customizable tool for SARS-CoV-2 sequence analysis and host data integration.
It offers a unique solution not currently available, supporting research, diagnostics, and viral surveillance.
The system facilitates secure data integration within organizational or hospital settings for improved public health insights.